Camilla Petrycer Hansen

Camilla Petrycer Hansen, PhD, Cand. Pharm, is a Principal at Novo Holdings and a Hemab Board Observer. Previously, she served as Senior Manager, Business Development at Novozymes and Business Development Manager at Statens Serum Institut. She earned a PhD in Medicinal Chemistry and a Cand. Pharm. in Pharmaceutical Sciences from the University of Copenhagen, Denmark.